Executive Series 26 Jun 18: Wattle Health Australia (WHA) CEO, Lazarus Karasavvidis, page-108

Am well aware of BAL as you know.

But for WHA, you are sliding the conversation away from the initial point of discussion, your good at that... . What is the risk for the company if the SAMR result is not as successful as they are betting and what mitigation does the company have in place. I agree on the organic observation as that is one part of their mitigation and it also offers a second opportunity for the business as it quietly goes about securing access to and supply of the majority of organic milk produced in AU, mainly out of Victoria.